Biologics Safety Testing Market Size, Share, Trends, Growth, Analysis and Forecast 2028

Zion Market Research has published a new report titled "Biologics Safety Testing Market by Product (Services, Instruments and Reagents, and Kits); by Test Type (Bioburden tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Cell Line Authentication and Characterization Tests, Sterility Tests, Endotoxin Tests, and Other Test Types); by Application (Tissue and Tissue-related Products Testing, Cellular and Gene Therapy, Blood and Blood-related Products Testing, Vaccine and Therapeutics Development and Stem Cell Research): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2025".

According to the report, global demand for the biologics safety testing market was valued at approximately USD 3.16 billion in 2018 and is expected to generate revenue of around USD 6.79 billion by end of 2025, growing at a CAGR of around 11.6% between 2019 and 2025.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭@https://www.zionmarketresearch.com/sample/biologics-safety-testing-market

Biologics drugs or products are derived from biological sources or are manufactured using living microorganisms, animal or plant cells. The majority of the biologics available in the market are derived using recombinant DNA technology. These biologics can be large or small polypeptides, products purified from serum and blood, antitoxins, vaccines, viruses, toxins, proteins, glycoproteins, etc. Biologics have revolutionized the management and treatment of various chronic illnesses including cancer, rheumatoid arthritis, cardiovascular diseases, diabetes, etc. Biologics safety is an important concern and parameter for biologics manufacturers for regulatory compliance and uses in animals and humans.

Global biologics safety testing market growth is supported by various factors such as increasing chronic disease burden and growing demand for biologics for treating diabetes, cancer, cardiovascular diseases, and other chronic diseases, rapid growth in new product launches, increasing investments in life science R&D and growth in biopharmaceutical and pharmaceutical research. However, longer approval time and stringent regulatory requirements may act as restraining factors for market growth. Emerging markets and growth in demand for pharmaceutical outsourcing are expected to bring new growth avenues for major market players in biologics safety testing.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 @https://www.zionmarketresearch.com/report/biologics-safety-testing-market

The global biologics safety testing market is segmented based on product, technology, test type, application, and region. Based on product, the global biologics safety testing market is categorized into instruments, services and reagents, and kits. Repeated and consistent use of reagents and kits led to the largest market share of the reagents and kits segment in 2018. The services segment is projected to register the highest growth in the coming years due to the growing demand for outsourcing services.

Based on test types biologics safety testing market is categorized into cell line authentication and characterization tests, adventitious agent detection, sterility, endotoxin, bioburden, residual host contamination detection tests, and other test types. The market was dominated by endotoxin test segment in 2018. The sterility test type segment will register the highest CAGR in the coming years.

The application segment market is categorized into vaccine and therapeutics development, cellular and gene therapy, blood and blood-related product testing, stem cell research, and tissue and tissue-related product testing. Growth in therapeutic drug and vaccine development projects by key pharmaceutical and biopharmaceutical companies has led to increasing adoption of biologics safety testing and thus accounted for the largest market share in 2018.

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭@https://www.zionmarketresearch.com/inquiry/biologics-safety-testing-market

North America held largest market share in 2018 for global biologics safety testing. Growing emphasis on novel therapeutics and vaccine development by biopharmaceutical and pharmaceutical companies, availability of funds, developed R&D infrastructure, growing R&D investments, and technological advancements are factors driving the market in this region. Europe was the second leading regional market. An increase in biologics development activities, high R&D spending, the presence of developed infrastructure and government support for R&D are some of the factors that boost the market growth in this region. Latin America is estimated to register considerable growth in the coming years.

Asia Pacific region will exhibit the highest CAGR for the biologics safety testing market in the coming years. Emphasis on capturing growth opportunities in developing nations by contract research organizations, increasing chronic disease burden, and increase in R&D spending are factors that promote biologics safety testing market growth in the Asia Pacific. Lack of funds and infrastructure may act as restraining factors for market growth in the Middle East and Africa.

𝐏𝐫𝐨𝐦𝐢𝐧𝐞𝐧𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐫𝐞
Merck KGaA
SGS SA
Charles River Laboratories
Toxikon Corporation
Lonza Group LTD.
Cytovance Biologics Inc.
Pace Analytical Services Inc.
Sartorius AG WuXi Apptec
Thermo Fisher Scientific Inc.

𝐓𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐨𝐟 𝐠𝐥𝐨𝐛𝐚𝐥 𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐬𝐚𝐟𝐞𝐭𝐲 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐬 𝐟𝐨𝐥𝐥𝐨𝐰𝐬:

𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐒𝐚𝐟𝐞𝐭𝐲 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭

Reagents and Kits
Services
Instruments

𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐒𝐚𝐟𝐞𝐭𝐲 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐁𝐲 𝐓𝐞𝐬𝐭 𝐓𝐲𝐩𝐞

Endotoxin Tests
Sterility Tests
Cell Line Authentication and Characterization Tests
Residual Host Contamination Detection Tests
Adventitious Agent Detection Tests
Bioburden tests
Other Tests

𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐒𝐚𝐟𝐞𝐭𝐲 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Vaccine and Therapeutics Development
Blood and Blood-related Products Testing
Cellular and Gene Therapy
Tissue and Tissue-related Products Testing
Stem Cell Research

𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐒𝐚𝐟𝐞𝐭𝐲 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us-after all-if you do well, a little of the light shines on us.

This release was published on openPR.